Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (391-400 of 706) with videos related to

Pageof 71
Sort By:
Chest|June 8, 2013
Prognostic significance of the extent of lymph node involvement in stage II-N1 non-small cell lung cancerZi-Ming Li, Zheng-Ping Ding, Qing-Quan Luo, et al.
Oncogenesis|September 8, 2019
Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancerYing Yang, Ziming Li, Hong Yuan, et al.
NPJ Precision Oncology|July 26, 2024
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significanceShengnan Chen, Tao Hu, Jikai Zhao, et al.
Microsystems & Nanoengineering|August 30, 2024
Ultrasensitive SERF atomic magnetometer with a miniaturized hybrid vapor cellYintao Ma, Yao Chen, Mingzhi Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2024
EGFR-mutant NSCLC may remodel TME from non-inflamed to inflamed through acquiring resistance to EGFR-TKI treatmentQianqian Chen, Liliang Xia, Jingze Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2026
Brief Report: Aumolertinib as a Switch Therapy in Osimertinib-Intolerant NSCLC: The ACTIVE TrialZiming Li, Biao Yao, Chun Huang, et al.
European Journal of Pharmacology|June 21, 2016
WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathwayShun Lu, Hao Liu, Lihe Lu, et al.
International Immunopharmacology|November 19, 2018
PD-1 blockade augments humoral immunity through ICOS-mediated CD4<sup>+</sup> T cell instructionMeiyu Zhang, Liliang Xia, Yi Yang, et al.
Cancer Medicine|May 31, 2020
Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 studyJianhua Chang, Gongyan Chen, Dong Wang, et al.
BMC Musculoskeletal Disorders|December 2, 2024
Are all cases of floating hip the same? Further understanding of floating hipXiaofeng Zhou, Yu Liu, Ajuan Zhang, et al.
Pageof 71

Showing results (391-400 of 706) with videos related to

Sort By:
Pageof 71
Chest|June 8, 2013
Prognostic significance of the extent of lymph node involvement in stage II-N1 non-small cell lung cancerZi-Ming Li, Zheng-Ping Ding, Qing-Quan Luo, et al.
Oncogenesis|September 8, 2019
Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancerYing Yang, Ziming Li, Hong Yuan, et al.
NPJ Precision Oncology|July 26, 2024
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significanceShengnan Chen, Tao Hu, Jikai Zhao, et al.
Microsystems & Nanoengineering|August 30, 2024
Ultrasensitive SERF atomic magnetometer with a miniaturized hybrid vapor cellYintao Ma, Yao Chen, Mingzhi Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2024
EGFR-mutant NSCLC may remodel TME from non-inflamed to inflamed through acquiring resistance to EGFR-TKI treatmentQianqian Chen, Liliang Xia, Jingze Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2026
Brief Report: Aumolertinib as a Switch Therapy in Osimertinib-Intolerant NSCLC: The ACTIVE TrialZiming Li, Biao Yao, Chun Huang, et al.
European Journal of Pharmacology|June 21, 2016
WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathwayShun Lu, Hao Liu, Lihe Lu, et al.
International Immunopharmacology|November 19, 2018
PD-1 blockade augments humoral immunity through ICOS-mediated CD4<sup>+</sup> T cell instructionMeiyu Zhang, Liliang Xia, Yi Yang, et al.
Cancer Medicine|May 31, 2020
Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 studyJianhua Chang, Gongyan Chen, Dong Wang, et al.
BMC Musculoskeletal Disorders|December 2, 2024
Are all cases of floating hip the same? Further understanding of floating hipXiaofeng Zhou, Yu Liu, Ajuan Zhang, et al.
Pageof 71